The Wockhardt Biotech Park was commissioned in September 2004 at Aurangabad, India. It was inaugurated by the then President of India, Dr. A P J Abdul Kalam. This state-of-the-art complex comprises six dedicated manufacturing facilities, with small to large scale manufacturing capabilities and is built to comply with US FDA and EMEA cGMP standards.
It has both API & Formulation facilities and the API facilities can cater to different expression systems like Bacterial, Mammalian and Yeast. By leveraging both our technological edge and cost efficiencies, and also India’s competitive advantage, we will also export our products from this biotechnology complex worldwide. The complex has the capacity to cater to 10-15% of the global demand for major biopharmaceuticals.